The global 3D neuroscience market was anticipated to reach a valuation of US$ 32.7 billion in the year 2022. With a CAGR of 3.82% from 2023 to 2033, this market is expected to reach US$ 33.95 billion by 2023 and US$ 49.39 billion by 2033.
3D neuroscience is a comprehensive domain that emphasizes the structural, psychosocial, evolutionary computing, cellular, developmental, molecular, and medicinal elements of the nervous system. For a better knowledge of the etiology and signs of chronic neurological illnesses including epilepsy and Alzheimer's disease, 3D neuroscience offers applications in a variety of fields.
Data Points
Key Statistics
Expected Market Value of 3D Neuroscience in 2023
US$ 33.95 billion
Expected Market Value of 3D Neuroscience in 2033
US$ 49.39 billion
Growth Rate (2023 to 2033)
3.82% from 2023 to 2033
Proteomic techniques, which are in great demand because of their accessibility, are actively utilized in neuroscience. Technological advancements encourage the progress of neuro-microscopy and the growth of the neuroscience industry. The market for 3D neurosciences is anticipated to expand quickly over the projected period as a result of technological progress.
The primary reason that is anticipated to fuel the growth of the worldwide 3D neuroscience market is the rising incidence of neurological ailments including Alzheimer's disease, cerebral stroke, and epilepsy. Moreover, the development of the global 3D Neuroscience market will be favorably impacted by increased breakthroughs in the fields of neuroscience as well as neurotechnology. Moreover, prominent competitors' increased product launch activity is anticipated to fuel market expansion.
For instance, Bruker has introduced the Ultima NeuraLight 3D imaging technology for neuroscience uses. The 3D holographic NeuraLight module is a cutting-edge technology used to decode neural connections and neural networks in multicellular brain research. Also, increased government financing and R&D efforts will considerably fuel industry expansion over the next years.
The increasing demand for neuroimaging technology and the continuous study and inquiry into brain mapping are two additional key growth-inducing factors. Also, the governments of several nations are actively working to increase public understanding of neurological diseases and the many treatment options. Also, the market is growing as more neurologic disorders are being diagnosed using microscopy, magnetic resonance imaging (MRI), and electrophysiological technologies.
Various innovative research is being conducted in this domain thoroughly for the last two years. For example, a recently created pop-up electrode tool can help with 3D brain mapping by collecting in-depth data on individual neurons as well as their connections while minimizing the risk of harming brain tissue. Researchers can produce sensor electrodes that are equivalent to current manufacturing in terms of resolution and performance. Nevertheless, before they are implanted in the brain, they can be popped up into 3D geometry. They are comparable to children's pop-up books in that they are flat and compressible. The 2D is converted to 3D. It gives a 3D gadget performance that is on par with 2D. Such developments are expected to open up new avenues in the market for 3D neurosciences from 2023 to 2033.
Some other developments by the key players in this domain are:
In February 2022, NeuroNexus Technologies unveiled the NeuroNexus Summa Framework. For experienced electrophysiologists as well as life scientists that need to swiftly incorporate electrical signal readings from biological tissues and cells into the research process, a solution has been developed.
In December 2021, the Brain Tumor Foundation and Hyperfine, Inc., a pioneering manufacturer of medical devices, entered a collaboration agreement. Through this arrangement, the former intended to leverage the company’s Swoop devices, the very first range of transportable magnetic resonance imaging (MRI) systems to get FDA certification.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
3D Neuroscience Market Overview
The revolutionary change in technology has led to a vast improvement in various medical fields. Neuroscience among them is one of the most prominent to witness drastic improvement due to constantly changing technology. High-quality intra-operative systems and 3D printing devices have resulted in improving the quality and safety of neurosurgery.
Global 3D neuroscience can be divided based on brain imaging, neuro-microscopy, electrophysiology, and neuro proteomic analysis. The 3D neuroscience market is expected to grow at a rapid rate in the forecast period due to the increasing prevalence of neurological disorders. Brain imaging is expected to contribute a large no. of market share in the forecast period.
The impact of COVID-19 on the 3D neuroscience market has started to be felt. The breakout of this disease led to lockdowns across the globe which has slowed down the growth of many markets 3D neuroscience market is no different. However, the market is expected to catch up and grow rapidly in the forecast years.
3D Neuroscience Market: Drivers and Restraints
The rising disease burden of neurological disorders such as cerebral stroke, Alzheimer’s disease, epilepsy, etc. has increased the demand for neurological advancement.
Therefore, it may act as one of the leading drivers of 3D neuroscience market. Advancement in the field of neuroscience and neuro-technology is also expected to drive the growth of 3D neuroscience market. Increasing research and development expenditure and government funding may also contribute towards the growth of the market. However, the high cost of neurological devices may limit the growth of 3D neuroscience market.
Find your sweet spots for generating winning opportunities in this market.
3D Neuroscience Market: Overview
The global market for 3D neuroscience market is estimated to experience significant growth during the forecast period due to increasing neurological disorders. Based on technology, the global 3D neuroscience market is divided into brain imaging, neuro-microscopy, electrophysiology, and neuroproteomics analysis.
Brain imaging is expected to constitute a major market share in the 3D neuroscience market due to the increasing prevalence of neurological disorders and tumors in the brain that may further lead to cancer. However, the other segments may also generate a large amount of revenue.
Based on components the 3D neuroscience market may be divided into instruments and consumables and software and services. Software and services are expected to generate huge revenue due to the change in technology which will project precise diagnosis.
3D Neuroscience Market: Regional-wise Outlook
Geographically, the 3D neuroscience market is segmented into seven regions viz. South Asia, East Asia, Europe, Latin America, North America, Oceania, and Middle East, and Africa. North America is expected to account for the largest share of the 3D neuroscience market due to the increasing prevalence of stroke.
According to the centers for disease control and prevention (CDC), about 140,000 American deaths result from stroke each year, which is 1 out of 20 deaths. Europe is expected to have the second largest market for the global 3D neuroscience market due to increasing neuroscience studies and acceptance of diagnosis treatment.
However, East Asia is expected to observe substantial growth in the 3D neuroscience market due to the availability of funds for research and development. On the other hand, South Asia is anticipated to experience fastest growth in the 3D neuroscience market as a result of the rising incidence of CNS disorders in developing countries.
India and China are expected to be major contributors to the 3D neuroscience market in South Asia as these countries comprise a large no. of geriatric population.
Developing medical infrastructure and increasing awareness of neurological disorders may lead to steady growth in Latin America. In the Middle East and Africa, market growth is expected to be limited due to slow economic growth, underdeveloped infrastructure, and lower access to technological advancement.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
3D Neuroscience Market: Key players
Some of the players identified in the 3D neuroscience market include:
Doric lenses Inc.
GE Healthcare
Siemens Helthineers
Laserglow Technologies
Mightex Systems
Kendall Research Systems
Neuronexus Technologies
Prixmatic Ltd.
Noldus Information Technology
Bioserve GmbH
The report is a compilation of first-hand information, qualitative and quantitative assessments by industry analysts, and inputs from industry experts and industry participants across the value chain.
The report provides an in-depth analysis of parent market trends, macroeconomic indicators, and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology Matrix
Value Chain
Regional analysis of the 3D neuroscience market report includes
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa
3D Neuroscience Market: Segmentation
Tentatively, the global 3D neuroscience market has been segmented on the basis of technology, component, and end-user.
